Drug giants Novartis and Glaxo today unveiled a series of transactions worth more than $20 billion that transforms both companies, the Wall Street Journal reports.
Drug giants Novartis and Glaxo today unveiled a series of transactions worth more than $20 billion that transforms both companies, the Wall Street Journal reports.